previou
studi
lycorin
natur
alkaloid
extract
amaryllidacea
exhibit
antileukemia
effect
vitro
determin
whether
lycorin
antitumor
effect
vivo
seri
experi
carri
studi
cell
inocul
iv
sever
combin
immunodefici
scid
mice
mice
irradi
total
bodi
receiv
cgi
c
irradi
treatment
given
day
day
day
lycorin
mgkgday
ip
found
decreas
percentag
immatur
granular
leukocyt
monocyt
among
peripher
blood
cell
mean
surviv
time
lycorinetr
group
longer
control
group
compar
asynchron
cytosin
arabinosid
arac
treat
mgkgday
ip
group
treatment
lycorin
effect
lycorin
also
found
allevi
infiltr
tumor
cell
liver
bone
marrow
scid
mice
inocul
cell
treat
lycorin
sever
advers
effect
observ
studi
reveal
lycorin
test
human
leukemia
xenograft
model
appear
exhibit
antitumor
activ
vivo
use
therapi
acut
promyelocyt
leukemia
leukemia
consid
one
lifethreaten
cancer
today
approxim
death
male
femal
unit
state
attribut
leukemia
acut
promyelocyt
leukemia
apl
common
type
leukemia
present
chemotherapeut
agent
extrem
use
treat
leukemia
find
novel
antitumor
chemotherapeut
medicin
deriv
natur
materi
becom
import
research
object
aim
new
drug
design
mani
natur
compound
alreadi
found
exhibit
signific
antitumor
effect
tea
polyphenol
induc
cell
apoptosi
arrest
antimitot
activ
mediat
casticin
albatrellu
confluen
abil
inhibit
growth
tumor
cell
induct
apoptosi
extract
narcissu
tazetta
var
chinensi
strongli
decreas
surviv
rate
mani
tumor
cell
line
lycorin
natur
alkaloid
extract
amaryllidacea
shown
variou
pharmacolog
microbiolog
effect
research
reveal
lycorin
inhibit
protein
synthesi
eukaryot
cell
acetylcholinesteras
activ
presenc
calprotectin
lycorin
shown
inhibit
protein
synthesi
cell
apoptosi
cell
lycorin
found
potent
antivir
activ
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
recent
report
lycorin
could
effect
arrest
cell
cycl
phase
induc
apoptosi
cell
treatment
human
multipl
meyloma
cell
line
lycorin
typic
apoptot
event
could
observ
result
also
show
lycorin
abl
block
cell
cycl
phase
downregul
cyclin
previou
studi
focus
signific
antitumor
effect
lycorin
howev
antitumor
effect
lycorin
vivo
remain
unknown
therefor
import
determin
therapeut
effect
lycorin
leukemia
anim
model
scid
mice
wide
use
cancer
research
especi
antileukemia
research
provid
system
model
studi
biolog
human
leukemia
explor
efficaci
novel
leukemia
therapi
program
previous
leukemia
model
scid
mice
success
set
human
leukemia
cell
could
detect
bone
marrow
spleen
lymph
node
scid
mice
pattern
resembl
human
acut
leukemia
studi
effect
lycorin
apl
vivo
evalu
human
leukemia
xenograft
model
ie
scid
mice
inocul
cell
although
model
would
complet
reflect
situat
patient
leukemia
human
apl
cell
line
purchas
american
type
cultur
collect
cell
routin
cultur
rpmi
medium
gibco
supplement
heatinactiv
fetal
bovin
serum
fb
invitrogen
kul
benzylpenicillin
mgl
streptomycin
c
humidifi
atmospher
co
cell
split
dilut
everi
day
lycorin
latoxan
franc
dissolv
dimethyl
sulfoxid
dmso
sigma
stock
solut
dilut
normal
salin
prior
usag
asynchron
cytosin
arabinosid
arac
inject
shanghai
hualian
pharmaceut
co
ltd
china
dilut
salin
prior
usag
femal
balbc
scid
mice
week
old
obtain
shanghai
laboratori
anim
center
chines
academi
scienc
maintain
specif
pathogenfre
facil
lab
anim
center
central
south
univers
mice
allow
adjust
new
environ
week
twentyfour
hour
mice
irradi
total
bodi
cgi
c
irradi
diminish
natur
killer
cell
activ
mice
inocul
cell
iv
via
tail
vein
day
mice
bear
apl
cell
random
per
group
group
treat
accord
follow
protocol
control
normal
salin
ip
b
lycorin
mgkgday
ip
c
lycorin
mgkgday
ip
arac
mgkgday
ip
treatment
given
day
day
day
scid
mice
inocul
iv
cell
treat
drug
tail
blood
sampl
taken
mice
everi
day
day
sampl
smear
onto
glass
microscop
slide
stain
use
wright
stain
percentag
immatur
granular
leukocyt
monocyt
among
peripher
blood
cell
monitor
mice
surviv
time
result
record
express
mean
surviv
time
percentag
treat
group
divid
control
group
treat
vs
control
tc
increas
life
span
il
express
mean
surviv
time
treat
group
minu
control
group
mean
surviv
time
control
group
nation
cancer
institut
nci
criteria
tc
exceed
il
exceed
indic
drug
signific
antitumor
activ
evalu
toxic
sideeffect
lycorin
mice
weight
mice
monitor
day
describ
previous
scid
mice
bear
human
leukemia
sacrif
painlessli
mice
close
death
bone
marrow
sampl
thighbon
mice
obtain
flush
salin
smear
onto
glass
microscop
slide
stain
use
wright
stain
tissu
excis
organ
includ
liver
spleen
bone
fix
formaldehyd
embed
paraffin
section
stain
hematoxylin
eosin
check
presenc
absenc
tumor
cell
microscop
data
analyz
use
pair
student
ttest
probabl
score
p
consid
statist
signific
compar
contemporan
control
group
p
compar
contemporan
lycorin
group
mgkgday
p
everi
seven
day
day
treatment
tail
blood
sampl
taken
mice
sampl
smear
onto
glass
microscop
slide
stain
wright
stain
percentag
immatur
granular
leukocyt
monocyt
mice
monitor
among
peripher
blood
cell
mice
inocul
iv
cell
treatment
percentag
immatur
granular
leukocyt
monocyt
among
peripher
blood
cell
control
group
compar
high
wherea
percentag
immatur
granular
leukocyt
monocyt
experi
group
decreas
compar
control
group
day
day
percentag
immatur
granular
leukocyt
monocyt
among
peripher
blood
cell
high
dosag
lycorin
mg
kgday
group
signific
decreas
p
also
observ
high
dosag
lycorin
mgkgday
effect
low
dosag
lycorin
mgkgday
day
tabl
furthermor
treatment
either
high
low
dosag
lycorin
shown
effect
treatment
arac
mgkgday
data
shown
signific
differ
mean
surviv
time
control
group
ae
day
rang
day
arac
treat
group
ae
day
rang
day
comparison
mean
surviv
time
group
receiv
low
dosag
lycorin
mgkgday
ae
day
rang
day
il
tc
valu
respect
mean
surviv
time
group
receiv
high
dosag
lycorin
mgkgday
ae
day
rang
day
il
tc
valu
respect
mean
surviv
time
two
lycorinetr
group
compar
control
group
arac
treat
group
p
tabl
fig
antitumor
activ
lycorin
vivo
investig
use
histopatholog
analysi
typic
leukemia
cell
observ
marrow
smear
control
group
fig
marrow
caviti
sternal
bone
control
group
chang
sawtooth
fig
wherea
marrow
caviti
sternal
bone
lycorinetr
group
normal
fig
big
abnorm
cell
observ
side
parenchyma
bone
fig
liver
control
group
fig
find
indic
tumor
cell
easili
wide
found
liver
bone
marrow
mice
control
group
wherea
fewer
tumor
cell
detect
tissu
mice
belong
lycorinetr
group
addit
sever
advers
effect
weight
loss
observ
mice
receiv
lycorin
tabl
mean
weight
scid
mice
control
group
day
day
ae
g
ae
g
ae
g
ae
g
respect
two
scid
mice
group
develop
abdomin
lump
meanwhil
mean
weight
group
receiv
low
dosag
lycorin
mgkgday
ae
g
ae
g
ae
g
ae
g
respect
mean
weight
group
receiv
high
dosag
lycorin
mgkgday
ae
g
ae
g
ae
g
ae
g
respect
tabl
effect
lycorin
surviv
day
scid
mice
inocul
cell
femal
balbc
scid
mice
week
old
inject
iv
cell
treatment
lycorin
arac
start
day
cell
inject
tc
treat
vs
control
il
increas
life
span
p
compar
control
group
p
compar
arac
treat
group
p
compar
control
group
p
compar
arac
treat
group
day
day
weight
lycorin
treat
mice
decreas
slightli
day
phenomena
nt
exist
observ
vivo
antileukemia
effect
lycorin
extend
previou
vitro
result
human
leukem
cell
scid
mice
transplant
human
apl
cell
display
high
degre
engraft
prolifer
human
tumor
cell
among
peripher
blood
cell
percentag
immatur
granular
leukocyt
monocyt
among
peripher
blood
cell
mice
treat
lycorin
decreas
compar
control
group
p
show
lycorin
inhibit
prolifer
also
induc
death
tumor
cell
effect
compar
control
group
il
valu
group
receiv
low
dosag
mg
kgday
high
dosag
mgkgday
lycorin
respect
indic
lycorin
antitumor
activ
mean
surviv
time
lycorinetr
group
longer
arac
treat
group
suggest
lycorin
effect
arac
scid
mice
inocul
cell
control
group
develop
infiltr
tumor
cell
liver
bone
marrow
peripher
blast
wherea
lycorin
could
allevi
infiltr
tumor
cell
sever
advers
effect
observ
low
high
dosag
lycorin
earli
period
treatment
day
antitumor
effect
high
dosag
mgkgday
lycorin
better
low
dosag
mgkgday
mean
surviv
time
significantli
improv
dosag
lycorin
increas
treatment
schedul
carri
earli
treatment
could
elimin
tumor
cell
fulli
complex
dysfunct
cancer
cell
import
evalu
activ
combin
therapeut
shown
lycorin
potent
antitumor
compound
addit
previou
studi
show
lycorin
signific
antitumor
effect
vitro
present
studi
demonstr
lycorin
exhibit
potent
antitumor
activ
xenograft
model
although
scid
mice
model
use
studi
limit
complet
reflect
situat
patient
acut
leukemia
result
suggest
treatment
use
therapi
apl
femal
balbc
scid
mice
week
old
inject
iv
cell
mice
weigh
day
day
day
day
